Mark D. Bunting

1.2k total citations
16 papers, 708 citations indexed

About

Mark D. Bunting is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mark D. Bunting has authored 16 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Mark D. Bunting's work include T-cell and B-cell Immunology (9 papers), Chemokine receptors and signaling (7 papers) and Immunotherapy and Immune Responses (5 papers). Mark D. Bunting is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Chemokine receptors and signaling (7 papers) and Immunotherapy and Immune Responses (5 papers). Mark D. Bunting collaborates with scholars based in Australia, United States and United Kingdom. Mark D. Bunting's co-authors include Shaun R. McColl, Iain Comerford, Ervin E. Kara, Yuka Harata‐Lee, Carly E. Gregor, Sarah Haylock‐Jacobs, W. Reid Litchfield, Heinrich Körner, Robert J. B. Nibbs and Kevin Fenix and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Mark D. Bunting

15 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Bunting Australia 11 450 314 171 64 41 16 708
David M. Gravano United States 9 539 1.2× 208 0.7× 192 1.1× 30 0.5× 51 1.2× 16 839
Esther Durán Spain 14 654 1.5× 399 1.3× 113 0.7× 105 1.6× 48 1.2× 46 913
Luciano Castiello United States 17 425 0.9× 302 1.0× 270 1.6× 61 1.0× 73 1.8× 30 842
Laëtitia Le Texier Australia 14 335 0.7× 133 0.4× 95 0.6× 75 1.2× 37 0.9× 30 586
Caroline Schmutz United Kingdom 10 503 1.1× 210 0.7× 256 1.5× 48 0.8× 66 1.6× 12 961
Pulak Tripathi United States 18 708 1.6× 236 0.8× 287 1.7× 36 0.6× 68 1.7× 26 1.0k
Russell B. Foxall Portugal 20 779 1.7× 366 1.2× 250 1.5× 73 1.1× 65 1.6× 45 1.3k
Nicolas Fasnacht United Kingdom 8 435 1.0× 117 0.4× 308 1.8× 39 0.6× 51 1.2× 10 789
Ronald Harning United States 16 403 0.9× 126 0.4× 148 0.9× 77 1.2× 36 0.9× 20 965
Frédérique‐Anne Le Gal France 19 705 1.6× 291 0.9× 254 1.5× 25 0.4× 68 1.7× 29 1.2k

Countries citing papers authored by Mark D. Bunting

Since Specialization
Citations

This map shows the geographic impact of Mark D. Bunting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Bunting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Bunting more than expected).

Fields of papers citing papers by Mark D. Bunting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Bunting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Bunting. The network helps show where Mark D. Bunting may publish in the future.

Co-authorship network of co-authors of Mark D. Bunting

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Bunting. A scholar is included among the top collaborators of Mark D. Bunting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Bunting. Mark D. Bunting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bunting, Mark D., G.I. Godahewa, Nicole O. McPherson, et al.. (2024). Investigating the potential of X chromosome shredding for mouse genetic biocontrol. Scientific Reports. 14(1). 13466–13466.
2.
Bunting, Mark D., G.I. Godahewa, Sandra Piltz, et al.. (2022). Leveraging a natural murine meiotic drive to suppress invasive populations. Proceedings of the National Academy of Sciences. 119(46). e2213308119–e2213308119. 19 indexed citations
3.
Bunting, Mark D., Marta Requesens, Adam Langenbucher, et al.. (2022). Extracellular matrix proteins regulate NK cell function in peripheral tissues. Science Advances. 8(11). eabk3327–eabk3327. 38 indexed citations
4.
Bunting, Mark D., et al.. (2022). Generation of Gene Drive Mice for Invasive Pest Population Suppression. Methods in molecular biology. 2495. 203–230. 5 indexed citations
5.
Bastow, Cameron R., Mark D. Bunting, Ervin E. Kara, et al.. (2021). Scavenging of soluble and immobilized CCL21 by ACKR4 regulates peripheral dendritic cell emigration. Proceedings of the National Academy of Sciences. 118(17). 28 indexed citations
6.
Varelias, Antiopi, Kate L. Ormerod, Mark D. Bunting, et al.. (2017). Acute graft-versus-host disease is regulated by an IL-17–sensitive microbiome. Blood. 129(15). 2172–2185. 52 indexed citations
7.
Varelias, Antiopi, Kate L. Ormerod, Mark D. Bunting, et al.. (2017). Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.. The Journal of Immunology. 198(Supplement_1). 82.8–82.8. 1 indexed citations
8.
Bunting, Mark D., Antiopi Varelias, Fernando Souza-Fonseca-Guimarães, et al.. (2016). GVHD prevents NK-cell–dependent leukemia and virus-specific innate immunity. Blood. 129(5). 630–642. 25 indexed citations
9.
Bunting, Mark D., Iain Comerford, Ervin E. Kara, Heinrich Körner, & Shaun R. McColl. (2014). CCR6 supports migration and differentiation of a subset of DN1 early thymocyte progenitors but is not required for thymic nTreg development. Immunology and Cell Biology. 92(6). 489–498. 8 indexed citations
10.
Comerford, Iain, Yuka Harata‐Lee, Mark D. Bunting, et al.. (2013). A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system. Cytokine & Growth Factor Reviews. 24(3). 269–283. 223 indexed citations
11.
Bunting, Mark D., Iain Comerford, Natalie Seach, et al.. (2012). CCX-CKR deficiency alters thymic stroma impairing thymocyte development and promoting autoimmunity. Blood. 121(1). 118–128. 28 indexed citations
12.
Haylock‐Jacobs, Sarah, Iain Comerford, Mark D. Bunting, et al.. (2011). PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. Journal of Autoimmunity. 36(3-4). 278–287. 65 indexed citations
13.
Comerford, Iain, Robert J. B. Nibbs, W. Reid Litchfield, et al.. (2010). The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood. 116(20). 4130–4140. 63 indexed citations
14.
Comerford, Iain, Mark D. Bunting, Kevin Fenix, et al.. (2010). An immune paradox: How can the same chemokine axis regulate both immune tolerance and activation?. BioEssays. 32(12). 1067–1076. 103 indexed citations
15.
Bunting, Mark D., Iain Comerford, & Shaun R. McColl. (2010). Finding their niche: chemokines directing cell migration in the thymus. Immunology and Cell Biology. 89(2). 185–196. 47 indexed citations
16.
Goolkasian, Paula & Mark D. Bunting. (1985). Calculation of time differences between pairs of clock times. Acta Psychologica. 58(3). 219–224. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026